Project Details
| Status | Active |
|---|---|
| Effective start/end date | 30/06/22 → 29/06/26 |
Funding
- Boehringer Ingelheim International GmbH: £3,680,293.95
NASH Disease Translational Accelerator (Retrospective Study 1)
- Henderson, Neil (Principal Investigator)
| Status | Active |
|---|---|
| Effective start/end date | 30/06/22 → 29/06/26 |